Literature DB >> 31969940

Dilated cardiomyopathy: A rare and late complication of the hemolytic-uremic syndrome.

Oumaima Naour1, Abdenasser Drighil1, Kaoutar Idouz2, Sellama Nadifi2, Fatima Ezzahra Rochdi3, Kenza Bouayed3, Nabiha Mikou3.   

Abstract

Hemolytic uremic syndrome (HUS) is a non-exceptional, progressive complication of acute gastroenteritis in children, especially secondary to Escherichia coli infection. It is responsible for significant morbidity and significant mortality (10% of deaths) because of acute renal failure which often complicates it. Dilated cardiomyopathy is a rare but critical extra renal manifestation of the HUS. This article highlights the importance of considering the diagnosis of associated cardiomyopathy in the acute phase of HUS and the following months. A five-year-old boy presented with HUS with acute renal failure requiring peritoneal dialysis for 24 days. No cardiac signs appeared during the acute phase of the disease. After dialysis and normalization of blood pressure, fluid, and electrolyte disturbance, severe dilated cardiomyopathy with cardiac failure appeared three months later without definite etiology. A review of the literature confirmed the rare and severe nature of cardiac lesions occurring in HUS. Dilated cardiomyopathy is a rare but important extra renal manifestation of the HUS and is best demonstrated by echocardiography. A cardiac manifestation should also be screened for in the acute phase of HUS and several months later. <Learning objective: The main message to draw from this case is that despite the rarity of cardiac complications, routine echocardiographic screening of children with hemolytic uremic syndrome should be performed both in the acute phase and during subsequent follow-up even in the absence of clinical signs because of severe prognosis of this complication, and it is therefore the investigation of choice.>.
© 2019 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Dilated cardiomyopathy; Hemolytic uremic syndrome; Rare and late complication

Year:  2019        PMID: 31969940      PMCID: PMC6962718          DOI: 10.1016/j.jccase.2019.07.002

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

Review 1.  New insights into the haemolytic uraemic syndromes.

Authors:  D V Milford; C M Taylor
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

2.  Epidemic hemolytic-uremic syndrome in children.

Authors:  H A Repetto
Journal:  Kidney Int       Date:  1997-12       Impact factor: 10.612

3.  Hemolytic-uremic syndrome.

Authors:  E Lieberman
Journal:  J Pediatr       Date:  1972-01       Impact factor: 4.406

Review 4.  Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome.

Authors:  R L Siegler
Journal:  J Pediatr       Date:  1994-10       Impact factor: 4.406

5.  [Cardiac involvement during classic hemolytic uremic syndrome].

Authors:  P Eckart; M Guillot; M Jokic; P Maragnes; B Boudailliez; J B Palcoux; V Desvignes
Journal:  Arch Pediatr       Date:  1999-04       Impact factor: 1.180

6.  Cardiomyopathy: a late complication of hemolytic uremic syndrome.

Authors:  A M Walker; L N Benson; G J Wilson; G S Arbus
Journal:  Pediatr Nephrol       Date:  1997-04       Impact factor: 3.714

7.  Dilated cardiomyopathy associated with haemolytic uraemic syndrome.

Authors:  J Poulton; C M Taylor; J V De Giovanni
Journal:  Br Heart J       Date:  1987-02

8.  Biomarkers detect involvement of acute myocardial injury in a paediatric haemolytic-uraemic syndrome patient.

Authors:  Daniel Palanca Arias; Marta López Ramón; Lorenzo Jiménez Montañés
Journal:  Cardiol Young       Date:  2016-02-03       Impact factor: 1.093

Review 9.  Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome.

Authors:  E G Gallo; C A Gianantonio
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

10.  Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children.

Authors:  Lars Krogvold; Thore Henrichsen; Anna Bjerre; Damien Brackman; Henrik Dollner; Helga Gudmundsdottir; Gaute Syversen; Pål Aksel Næss; Hans Jacob Bangstad
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-07-28       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.